Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01276184
Other study ID # HP-00047046
Secondary ID GCC 1063GCCMerck
Status Terminated
Phase N/A
First received
Last updated
Start date January 2011
Est. completion date June 15, 2016

Study information

Verified date July 2021
Source University of Maryland, Baltimore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Human papillomavirus (HPV) is the most common sexually transmitted disease among adolescent females in the United States. Our primary objective is to determine if Short Message Service (SMS) text message reminders increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care in an outpatient clinic setting. Secondary objectives of this study are: 1) to demonstrate the feasibility of using SMS text message reminders to increase adherence with Gardasil vaccination; and 2) to assess satisfaction and acceptability of text message reminders compared to telephone reminders among women who receive the text message arm of the intervention. The investigators hypothesize that receiving SMS text message reminders will increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SMS Text Message
Women in the SMS Text Message group that reschedule a vaccination visit will receive text message reminders one per day for each of the seven days prior to the rescheduled visit (or as many days as possible depending on when the rescheduled visit will take place - for example, if they call in and reschedule the visit to take place in 4 days, they will receive text messages for the 3 days prior to the rescheduled visit). Participants in both the Usual Care group and the SMS Text Message group will receive the standard reminder from the clinic for their re-scheduled appointment(s).

Locations

Country Name City State
United States Redwood Clinic Baltimore Maryland
United States Western-Penn Center Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
University of Maryland, Baltimore Merck Sharp & Dohme Corp.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants That Adhered to Vaccine Schedule Our primary objective is to determine if Short Message Service (SMS) text message reminders increase number of participants that adhered to the recommended 3 dose schedule for Gardasil compared to usual care in an outpatient clinic setting. at the end of the study (30 days after the third vaccination or 360 days after the first vaccination, whichever comes first)
See also
  Status Clinical Trial Phase
Completed NCT01595542 - A School Health Center Intervention to Increase Adolescent Vaccination N/A
Completed NCT01159093 - Giving Immunizations Through Vaccine Education N/A
Completed NCT03399396 - Increasing HPV Vaccination in Community-Based Pediatric Practices N/A